DIA — DiaSorin SpA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for DiaSorin SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,238	1,361	1,148	1,185	1,195
Cost of Revenue
Gross Profit	825	901	741	782	773
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	818	1,010	932	927	966
Operating Profit	419	351	216	258	229
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	399	326	201	242	212
Provision for Income Taxes
Net Income After Taxes	311	240	159	187	150
Minority Interest
Net Income Before Extraordinary Items
Net Income	311	241	160	188	156
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	311	241	160	188	156
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.7	4.62	3.17	3.46	3.28
Dividends per Share